Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>Mario Tumbarello, Pierluigi Viale, Carlo Tascini et al.|Clinical Infectious Diseases|2018Cited by 351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Francesca Raffaelli et al.|Clinical Infectious Diseases|2021Cited by 264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)Marco Falcone, Donatella Palazzo, Giusy Tiseo et al.|Clinical Infectious Diseases|2023Cited by 156
Use of colistin in adult patients: A cross-sectional studyDaniele Roberto Giacobbe, Małgorzata Mikulska, Carolina Saffioti et al.|Journal of Global Antimicrobial Resistance|2019Cited by 37
Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter pharmacokinetics study for Screening Antifungal Exposure in Intensive Care Units—the SAFE-ICU studyJason A. Roberts, Claire Roger, Fekade B. Sime et al.|Intensive Care Medicine|2025Cited by 33